Submacular hemorrhage following photodynamic therapy in the treatment of choroidal neovascularization;Hemorragia submacular tras terapia fotodinámica en el tratamiento de la neovascularización coroidea

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 81, Issue 12, 2006, Pages 685-692

  Díaz De Durana Santa Coloma, Enrique ^a   Fernandez Ares M L ^a   Iturralde Errea, D ^a   Salazar Diez J L ^a   Vazquez Cruchaga E ^a   Lopez Garrido J A ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Photodynamic therapy; Submacular hemorrhage; Verteporfin

Indexed keywords

ANTICOAGULANT AGENT; BENZOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT; PORPHYRIN;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; INCIDENCE; MALE; PHOTOCHEMOTHERAPY; RETINA HEMORRHAGE; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VITRECTOMY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; INCIDENCE; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETINAL HEMORRHAGE; RETROSPECTIVE STUDIES; VISUAL ACUITY; VITRECTOMY;

EID: 34248209212     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one year results of 2 randomized clinical trials - TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol 1999; 117: 1329-1345.
2. Bresslet NM; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-Tap report 2. Arch Ophthalmol 2001; 119: 198-207.
3. Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. one-year results of a randomized clinical trial. VIP report no.1. Ophthalmology 2001; 108: 841-852.
4. Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001; 131: 541-560.
5. Arnold JJ, Blinker KJ, Bressler NM, Bressler SB, Burdan A, Haynes L, et al. Acute severe visual acuity decrease after photodynamic therapy wtih verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3. Am J Ophthalmol 2004; 137: 683-696.
6. Do DV, Bressler NM, Bressler SB. Large submacular hemorrhages after verteporfin therapy. Am J Ophthalmol 2004; 137: 558-560.
7. Theodossiadis GP, Panaglotidis D, Georgalas IG, Moschos M, Theodossiadis PG. Retinal hemorrhage after photodynamic therapy in patients with subfoveal choroidal neovascularization caused by age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2003; 241: 13-18.
8. Gelisken F, Inhoffen W, Karim-Zoda K, Grisanti S, Partsch M, Voelker M, et al. Subfoveal hemorrhage after verteporfin photodynamic therapy in treatment of choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 2005; 243: 198-203.
9. Arroyo JG, Michaud N, Jacobiec FA. Choroidal neovascular membranes treated with photodynamic therapy. Arch Ophthalmol 2003; 121: 898-903.